Matinas BioPharma | Investor Presentation Deck | 31 slides · page 27 of 31
The slide highlights a $2.75M upfront payment and the strategic synergy between Matinas' LNC platform and BioNTech's mRNA expertise.
Pitch deck · traction · show_traction · dense density
Slide locked Sign in to view
Slide schematic 4/4
image 1/1 list 2/2 title 1/1
Components 4
infographic bullet bullet headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.